HIGHLIGHTS
- who: Commentary and colleagues from the Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong SAR, China have published the Article: Recommendations for Epstein-Barr virus-based screening for nasopharyngeal cancer in high- and intermediate-risk regions, in the Journal: (JOURNAL) of September/16,/2022
- how: At the meeting additional results were presented from an extended trial period in which participation among individuals (age inclusion extended to 30-69 years) from the screening arm was increased to 52 541 individuals with 8 years of follow-up. The first prospective . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.